BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Samanta J, Alden T, Gobeske K, Kan L, Kessler JA. Noggin protects against ischemic brain injury in rodents. Stroke 2010;41:357-62. [PMID: 20019326 DOI: 10.1161/STROKEAHA.109.565523] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Ingberg E, Dock H, Theodorsson E, Theodorsson A, Ström JO. Method parameters' impact on mortality and variability in mouse stroke experiments: a meta-analysis. Sci Rep 2016;6:21086. [PMID: 26876353 DOI: 10.1038/srep21086] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
2 Dizon ML, Maa T, Kessler JA. The bone morphogenetic protein antagonist noggin protects white matter after perinatal hypoxia-ischemia. Neurobiol Dis 2011;42:318-26. [PMID: 21310236 DOI: 10.1016/j.nbd.2011.01.023] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 3.2] [Reference Citation Analysis]
3 Divolis G, Stavropoulos A, Manioudaki M, Apostolidou A, Doulou A, Gavriil A, Dafnis I, Chroni A, Mummery C, Xilouri M, Sideras P. Activation of both transforming growth factor-β and bone morphogenetic protein signalling pathways upon traumatic brain injury restrains pro-inflammatory and boosts tissue reparatory responses of reactive astrocytes and microglia. Brain Commun 2019;1:fcz028. [PMID: 32954268 DOI: 10.1093/braincomms/fcz028] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
4 Wong JK, Chen L, Huang Y, Sehba FA, Friedel RH, Zou H. Attenuation of Cerebral Ischemic Injury in Smad1 Deficient Mice. PLoS One 2015;10:e0136967. [PMID: 26317208 DOI: 10.1371/journal.pone.0136967] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
5 Cho YE, Latour LL, Kim H, Turtzo LC, Olivera A, Livingston WS, Wang D, Martin C, Lai C, Cashion A, Gill J. Older Age Results in Differential Gene Expression after Mild Traumatic Brain Injury and Is Linked to Imaging Differences at Acute Follow-up. Front Aging Neurosci 2016;8:168. [PMID: 27468266 DOI: 10.3389/fnagi.2016.00168] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
6 Uemura MT, Ihara M, Maki T, Nakagomi T, Kaji S, Uemura K, Matsuyama T, Kalaria RN, Kinoshita A, Takahashi R. Pericyte-derived bone morphogenetic protein 4 underlies white matter damage after chronic hypoperfusion. Brain Pathol 2018;28:521-35. [PMID: 28470822 DOI: 10.1111/bpa.12523] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
7 Ogawa Y, Tsuji M, Tanaka E, Miyazato M, Hino J. Bone Morphogenetic Protein (BMP)-3b Gene Depletion Causes High Mortality in a Mouse Model of Neonatal Hypoxic-Ischemic Encephalopathy. Front Neurol 2018;9:397. [PMID: 29922215 DOI: 10.3389/fneur.2018.00397] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Zhan H, Li S, Sun J, Liu R, Yan F, Niu B, Zhang H, Wang X. Lettuce glycoside B ameliorates cerebral ischemia reperfusion injury by increasing nerve growth factor and neurotrophin-3 expression of cerebral cortex in rats. Indian J Pharmacol 2014;46:63-8. [PMID: 24550587 DOI: 10.4103/0253-7613.125171] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
9 Sabo JK, Heine V, Silbereis JC, Schirmer L, Levison SW, Rowitch DH. Olig1 is required for noggin-induced neonatal myelin repair. Ann Neurol 2017;81:560-71. [PMID: 28253550 DOI: 10.1002/ana.24907] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
10 Dummula K, Vinukonda G, Chu P, Xing Y, Hu F, Mailk S, Csiszar A, Chua C, Mouton P, Kayton RJ, Brumberg JC, Bansal R, Ballabh P. Bone morphogenetic protein inhibition promotes neurological recovery after intraventricular hemorrhage. J Neurosci 2011;31:12068-82. [PMID: 21865450 DOI: 10.1523/JNEUROSCI.0013-11.2011] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 4.9] [Reference Citation Analysis]
11 Brandli A, Gerhart J, Sutera CK, Purushothuman S, George-Weinstein M, Stone J, Bravo-Nuevo A. Role of Myo/Nog Cells in Neuroprotection: Evidence from the Light Damaged Retina. PLoS One 2017;12:e0169744. [PMID: 28099524 DOI: 10.1371/journal.pone.0169744] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
12 Chew LJ, DeBoy CA. Pharmacological approaches to intervention in hypomyelinating and demyelinating white matter pathology. Neuropharmacology 2016;110:605-25. [PMID: 26116759 DOI: 10.1016/j.neuropharm.2015.06.008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
13 Casey S, Goasdoue K, Miller SM, Brennan GP, Cowin G, O'Mahony AG, Burke C, Hallberg B, Boylan GB, Sullivan AM, Henshall DC, O'Keeffe GW, Mooney C, Bjorkman T, Murray DM. Temporally Altered miRNA Expression in a Piglet Model of Hypoxic Ischemic Brain Injury. Mol Neurobiol 2020;57:4322-44. [PMID: 32720074 DOI: 10.1007/s12035-020-02018-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
14 Heinonen AM, Rahman M, Dogbevia G, Jakobi H, Wölfl S, Sprengel R, Schwaninger M. Neuroprotection by rAAV-mediated gene transfer of bone morphogenic protein 7. BMC Neurosci 2014;15:38. [PMID: 24618040 DOI: 10.1186/1471-2202-15-38] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
15 Mausner-Fainberg K, Benhamou M, Golan M, Kimelman NB, Danon U, Marom E, Karni A. Specific Blockade of Bone Morphogenetic Protein-2/4 Induces Oligodendrogenesis and Remyelination in Demyelinating Disorders. Neurotherapeutics 2021. [PMID: 34159538 DOI: 10.1007/s13311-021-01068-9] [Reference Citation Analysis]
16 Zhang J, Chopp M. Cell-based therapy for ischemic stroke. Expert Opin Biol Ther 2013;13:1229-40. [PMID: 23738646 DOI: 10.1517/14712598.2013.804507] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
17 Zhao SC, Ma LS, Chu ZH, Xu H, Wu WQ, Liu F. Regulation of microglial activation in stroke. Acta Pharmacol Sin. 2017;38:445-458. [PMID: 28260801 DOI: 10.1038/aps.2016.162] [Cited by in Crossref: 117] [Cited by in F6Publishing: 120] [Article Influence: 29.3] [Reference Citation Analysis]
18 Grinspan JB. Inhibitors of Myelination and Remyelination, Bone Morphogenetic Proteins, are Upregulated in Human Neurological Disease. Neurochem Res 2020;45:656-62. [PMID: 32030597 DOI: 10.1007/s11064-020-02980-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
19 Yoo SW, Motari MG, Schnaar RL. Agenesis of the corpus callosum in Nogo receptor deficient mice. J Comp Neurol 2017;525:291-301. [PMID: 27339102 DOI: 10.1002/cne.24064] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]